75 results
424B3
MDAI
Spectral AI Inc - Ordinary Shares
23 Apr 24
Prospectus supplement
6:10am
2025.
Reimbursement
We expect to utilize our post-market clinical evidence and health economic impact analysis to submit to NHS for reimbursement … the DeepView System will be used in both inpatient and outpatient sites of service. The process of reimbursement varies greatly between the two
424B3
MDAI
Spectral AI Inc - Ordinary Shares
23 Apr 24
Prospectus supplement
6:08am
2025.
Reimbursement
We expect to utilize our post-market clinical evidence and health economic impact analysis to submit to NHS for reimbursement … the DeepView System will be used in both inpatient and outpatient sites of service. The process of reimbursement varies greatly between the two
424B3
MDAI
Spectral AI Inc - Ordinary Shares
19 Apr 24
Prospectus supplement
1:57pm
products or the reimbursement thereof. In addition, regulations and guidance are often revised or reinterpreted by the applicable competent authority … of or lower reimbursement for the procedures associated with the use of our DeepView System. The cost containment measures that payors and providers
8-K
2v3lmm0xs8niy9m
1 Apr 24
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
4:00pm
8-K
EX-99.1
4u7ky7 7n1vhqv
28 Mar 24
Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results
6:39pm
8-K
EX-99.1
5wuehx6
13 Feb 24
Regulation FD Disclosure
8:21am
S-8
EX-99.2
77s oiint1umz
9 Feb 24
Registration of securities for employees
8:33am
8-K
EX-99.1
vu5jthwweute5atqw1
5 Feb 24
Regulation FD Disclosure
10:34am
424B3
getjh
1 Feb 24
Prospectus supplement
4:42pm
424B3
86fu03
2 Jan 24
Prospectus supplement
4:30pm
8-K
EX-10.1
gxu7cdbc
27 Dec 23
Entry into a Material Definitive Agreement
8:31am
8-K
EX-10.2
6en5jx1 brpau7m5di1
27 Dec 23
Entry into a Material Definitive Agreement
8:31am